BIOPOL CHEMICALS LIMITED Fair Value
BIOPOL · Chemicals · Current price ₹46.15
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹73 | 32% ROE fading to 14% over ~10 yrs, on ₹33 book |
| Relative P/E | ₹433 | EPS × 52.1 peer-median P/E |
| Graham floor | ₹79 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is BIOPOL CHEMICALS LIMITED undervalued?
DocStoX estimates the fair value of BIOPOL CHEMICALS LIMITED at ₹167 per share, versus the current market price of ₹46. That puts the stock about +261.7% below our fair-value estimate, which we read as "Strong Buy". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹73), Relative P/E (₹433), Graham floor (₹79). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹73 (bear) to ₹167 (base) to ₹433 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on BIOPOL CHEMICALS LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.